CTL cytotoxicity against B16 tumor cells was 78.5%,and the cytotoxicity against H22 tumor cells was 21.4% in B16 HSP70-peptide complex group,indicating that CTL cytotoxicity original from HIFU-treated tumor had specific anti-tumor immunity.

• B16肿瘤HSP70-肽复合物组CTL对B16肿瘤细胞的杀伤率为78.；5%25；对H22细胞的杀伤率为21